Agios

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Agios and other ETFs, options, and stocks.

About AGIO

Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in a research engine, multiple novels, and investigational therapies in preclinical development. It focuses on cellular metabolism and classical hematology.

CEO

Brian M. Goff

CEOBrian M. Goff

Employees

488

Employees488

Headquarters

Cambridge, Massachusetts

HeadquartersCambridge, Massachusetts

Founded

2007

Founded2007

Employees

488

Employees488

AGIO Key Statistics

Market cap

2.15B

Market cap2.15B

Price-Earnings ratio

3.41

Price-Earnings ratio3.41

Dividend yield

—

Dividend yield—

Average volume

1.44M

Average volume1.44M

High today

$37.77

High today$37.77

Low today

$36.46

Low today$36.46

Open price

$37.50

Open price$37.50

Volume

529.07K

Volume529.07K

52 Week high

$62.58

52 Week high$62.58

52 Week low

$23.42

52 Week low$23.42

AGIO News

Seeking Alpha 4d

Agios falls as Leerink cites deaths linked to lead asset Pyrukynd

Healthcare On the Move Agios falls as Leerink cites deaths linked to lead asset Pyrukynd Aug. 04, 2025 10:13 AM ET Agios Pharmaceuticals, Inc. (AGIO) Stock By:...

Analyst ratings

67%

of 9 ratings

Buy

66.7%

Hold

33.3%

Sell

People also own

Based on the portfolios of people who own AGIO. This list is generated using Robinhood data, and it’s not a recommendation.